Description
Giredestrant potently competes with estradiol for binding and induces a conformational change within the ER ligand binding domain.Giredestrant has anti-tumor activity.Giredestrant, a non-steroidal ER ligand, is an orally active and selective estrogen receptor (ER) antagonist